Skip to main content
Qyuns Therapeutics Co., Ltd. logo

Qyuns Therapeutics Co., Ltd. — Investor Relations & Filings

Ticker · 2509 ISIN · CNE1000069W9 HKEX Manufacturing
Open in API
Filings indexed 192 across all filing types
Latest filing 2026-06-05 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 2509

About Qyuns Therapeutics Co., Ltd.

http://www.qyuns.net

Qyuns Therapeutics Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the research, development, industrialization, and commercialization of antibody drugs for autoimmune and allergic diseases. The company operates an integrated platform covering the entire value chain, from proprietary antibody discovery (including a rabbit antibody development platform) to cGMP-compliant, commercial-scale internal manufacturing. Qyuns focuses on improving drug accessibility and affordability in its target areas. Its robust pipeline features 10 drug candidates targeting major inflammatory pathways, such as IL-12/IL-23p40, IL-4R , IL-17A, IL-23p19, and TSLP. The pipeline addresses four key therapeutic areas: dermatology, rheumatology, respiratory, and digestive diseases, with several assets in late-stage clinical development.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 85% confidence The document is an FF305 Next Day Disclosure Return filed under Hong Kong Listing Rules, detailing changes in issued and treasury shares and a share repurchase (on-market buyback) by Qyuns Therapeutics Co., Ltd. It provides specific trading dates, number of shares repurchased, repurchase prices, closing balances, and confirmations of compliance with exchange rules. This is a report of the company buying back its own shares. According to the filing taxonomy, this falls under “Transaction in Own Shares” (POS).
2026-06-05 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 88% confidence The document is a Hong Kong Exchange “Next Day Disclosure Return” (Form FF305) reporting detailed share repurchase (treasury shares holdings) and changes in issued shares by the company. This is clearly a report of the company’s transactions in its own shares (share buybacks), matching the definition of Transaction in Own Shares. Therefore, the correct filing code is POS.
2026-06-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings Classification · 90% confidence The document is a HKEX Form FF301 “Monthly Return for Equity Issuer…” detailing movements in authorized share capital, issued and treasury shares, repurchases, and public float sufficiency for the month ended May 31, 2026. It is a recurring compliance filing under the Exchange Listing Rules rather than an annual or interim financial report, earnings release, or proxy material. It does not constitute a full Annual Report (10-K), Interim/Quarterly Report (IR), shareholder vote result (DVA), capital financing update (CAP) or any other more specific category. Therefore, it falls under the general Regulatory Filings category.
2026-06-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 86% confidence The document is a regulatory disclosure (Next Day Disclosure Return FF305) detailing share repurchases (buyback of treasury shares) under Hong Kong Listing Rules, with specific repurchase dates, prices, volumes, and closing balances. This is not an announcement of a general report, dividend, or AGM materials, but a transaction in the company's own shares. Therefore, it fits the “Transaction in Own Shares” category (POS).
2026-06-03 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return (Form FF305) filed under the Hong Kong Stock Exchange Listing Rules detailing changes in issued shares, treasury shares, and on‐market repurchases. It contains substantive data on the number of shares repurchased, prices, balances, and mandate details. This constitutes a transaction in the company’s own shares rather than an earnings release, board change, or annual report. Therefore, it should be classified under Transaction in Own Shares (POS).
2026-06-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is a Hong Kong Exchange “Next Day Disclosure Return” detailing changes in issued shares, treasury shares, and a detailed section on on-market share repurchases including prices, volumes, and confirmation of compliance. It is not an AGM or earnings release but a regulatory notice of the company’s own share transactions. Under our filing definitions, reports of share buybacks or sales of treasury shares are classified as “Transaction in Own Shares” (POS).
2026-06-01 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.